BioCentury | Apr 12, 2019
Financial News

Flagship-backed Axcella seeking NASDAQ IPO

...hopes to begin a pivotal Phase IIb/III trial in 2H20. Axcella, which was known as Pronutria...
BioCentury | Jun 21, 2017
Company News

Management tracks

...in the global healthcare practice at McKinsey & Co. Axcella, which was formerly known as Pronutria...
BioCentury | Jan 3, 2017
Company News

Management tracks

...intelligence and policy at H. Lundbeck A/S (Copenhagen, Denmark). Axcella, which was formerly known as Pronutria...
BioCentury | Feb 29, 2016
Financial News

Pronutria completes venture financing

Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2016-02-23 Type: Venture financing Raised: $42.5 million Investor: Nestle S.A. WIR Staff Neurology...
BioCentury | Feb 24, 2016
Financial News

Nestle invests $42.5M in Pronutria

...SIX:NESN). Pronutria develops amino acid-based therapeutics to treat muscle, neurological and liver disorders. This year, Pronutria...
...orally ingested protein with an amino acid combination and physicochemical profile optimized for myopenia conditions. Pronutria...
...therapeutics, the company is developing medical foods and supplements. Nestle Health's Greg Behar will join Pronutria's...
BioCentury | Dec 7, 2015
Company News

BioXcel, Pronutria deal

...Big Data Innovation Lab (BDI-Lab) to identify rare diseases for therapies that are amenable to Pronutria’s...
...standard of care. The partners did not respond to inquiries. BioXcel Corp. , Branford, Conn. Pronutria...
BioCentury | Jun 29, 2015
Company News

KineMed, Pronutria deal

...The companies partnered to use KineMed’s proteomics technology to evaluate the physiological effects of Pronutria’s biologics...
...restore cellular hemostasis. The companies did not disclose financial details. KineMed Inc. , Emeryville, Calif. Pronutria...
BioCentury | Jun 3, 2015
Company News

Management tracks

...Its pipeline includes Syntocinon , a nasal spray to promote lactation. Amino acid-based therapeutics developer Pronutria...
BioCentury | Jun 1, 2015
Financial News

Pronutria completes venture financing

Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2015-05-28 Type: Venture financing Raised: $39 million Investors: Fidelity; Flagship Ventures; and other investors WIR Staff...
BioCentury | May 29, 2015
Financial News

Pronutria raises $39M series C

...Existing investor Flagship Ventures and other undisclosed investors also participated, including individuals and family offices. Pronutria...
Items per page:
1 - 10 of 14
BioCentury | Apr 12, 2019
Financial News

Flagship-backed Axcella seeking NASDAQ IPO

...hopes to begin a pivotal Phase IIb/III trial in 2H20. Axcella, which was known as Pronutria...
BioCentury | Jun 21, 2017
Company News

Management tracks

...in the global healthcare practice at McKinsey & Co. Axcella, which was formerly known as Pronutria...
BioCentury | Jan 3, 2017
Company News

Management tracks

...intelligence and policy at H. Lundbeck A/S (Copenhagen, Denmark). Axcella, which was formerly known as Pronutria...
BioCentury | Feb 29, 2016
Financial News

Pronutria completes venture financing

Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2016-02-23 Type: Venture financing Raised: $42.5 million Investor: Nestle S.A. WIR Staff Neurology...
BioCentury | Feb 24, 2016
Financial News

Nestle invests $42.5M in Pronutria

...SIX:NESN). Pronutria develops amino acid-based therapeutics to treat muscle, neurological and liver disorders. This year, Pronutria...
...orally ingested protein with an amino acid combination and physicochemical profile optimized for myopenia conditions. Pronutria...
...therapeutics, the company is developing medical foods and supplements. Nestle Health's Greg Behar will join Pronutria's...
BioCentury | Dec 7, 2015
Company News

BioXcel, Pronutria deal

...Big Data Innovation Lab (BDI-Lab) to identify rare diseases for therapies that are amenable to Pronutria’s...
...standard of care. The partners did not respond to inquiries. BioXcel Corp. , Branford, Conn. Pronutria...
BioCentury | Jun 29, 2015
Company News

KineMed, Pronutria deal

...The companies partnered to use KineMed’s proteomics technology to evaluate the physiological effects of Pronutria’s biologics...
...restore cellular hemostasis. The companies did not disclose financial details. KineMed Inc. , Emeryville, Calif. Pronutria...
BioCentury | Jun 3, 2015
Company News

Management tracks

...Its pipeline includes Syntocinon , a nasal spray to promote lactation. Amino acid-based therapeutics developer Pronutria...
BioCentury | Jun 1, 2015
Financial News

Pronutria completes venture financing

Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2015-05-28 Type: Venture financing Raised: $39 million Investors: Fidelity; Flagship Ventures; and other investors WIR Staff...
BioCentury | May 29, 2015
Financial News

Pronutria raises $39M series C

...Existing investor Flagship Ventures and other undisclosed investors also participated, including individuals and family offices. Pronutria...
Items per page:
1 - 10 of 14